Bi2S3-embedded mesoporous silica nanoparticles for efficient drug delivery and interstitial radiotherapy sensitization

Biomaterials

Volumn 37, Issue , 2015, Pages 447-455

  Ma, Ming ^a   Huang, Yan ^b   Chen, Hangrong ^a   Jia, Xiaoqing ^a   Wang, Shige ^a   Wang, Zizheng ^b   Shi, Jianlin ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Bi2S3; Drug delivery; Mesoporous silica; Radiotherapy sensitization

Indexed keywords

DRUG DELIVERY; MESOPOROUS MATERIALS; NANOPARTICLES; RADIOTHERAPY; SILICA; TUMORS;

CLINICAL APPLICATION; CONTROLLED DRUG RELEASE; DIFFERENT TREATMENTS; EFFICIENT DRUG DELIVERY; LOADING EFFICIENCY; MESOPOROUS SILICA; MESOPOROUS SILICA NANOPARTICLES; THERAPEUTIC EFFECTS;

LOADING;

BISMUTH; BISMUTH TRISULFIDE; DOXORUBICIN; MESOPOROUS SILICA NANOPARTICLE; SILANOL; SILICA NANOPARTICLE; SULFIDE; UNCLASSIFIED DRUG; BISMUTH SULFIDE; NANOPARTICLE; SILICON DIOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CELL VIABILITY; CHEMORADIOTHERAPY; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; EXTERNAL BEAM RADIOTHERAPY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; RADIOSENSITIZATION; RADIOTHERAPY; STATIC ELECTRICITY; THERAPY EFFECT; TUMOR GROWTH; TUMOR VOLUME; ANIMAL; BRACHYTHERAPY; CELL DEATH; CHEMISTRY; DRUG EFFECTS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MULTIDRUG RESISTANCE; POROSITY; TUMOR CELL LINE; TUNEL ASSAY; ULTRASTRUCTURE;

ANIMALS; BISMUTH; BRACHYTHERAPY; CELL DEATH; CELL LINE, TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MULTIPLE; FLOW CYTOMETRY; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICE; NANOPARTICLES; POROSITY; SILICON DIOXIDE; SULFIDES;

EID: 84922336713     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.10.001     Document Type: Article

References (35)

1. Zheng Y., Hunting D.J., Ayotte P., Sanche L. Radiosensitization of DNA by gold nanoparticles irradiated with high-energy electrons. Radiat Res 2008, 169:19-27.
2. Kaur H., Pujari G., Semwal M.K., Sarma A., Avasthi D.K. Invitro studies on radiosensitization effect of glucose capped gold nanoparticles in photon and ion irradiation of HeLa cells. Nucl Instrum Meth B 2013, 301:7-11.
3. Xiao F.X., Zheng Y., Cloutier P., He Y.H., Hunting D., Sanche L. On the role of low-energy electrons in the radiosensitization of DNA by gold nanoparticles. Nanotechnology 2011, 22.
4. Ngwa W., Korideck H., Kassis A.I., Kumar R., Sridhar S., Makrigiorgos G.M., et al. Invitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds. Nanomed Nanotechnol 2013, 9:25-27.
5. Zheng Y., Cloutier P., Hunting D.J., Sanche L. Radiosensitization by gold nanoparticles: comparison of DNA damage induced by low and high-energy electrons. JBiomed Nanotechnol 2008, 4:469-473.
6. Stone N.N., Stock R.G. Long-term urinary, sexual, and rectal morbidity in patients treated with Iodine-125 prostate brachytherapy followed up for a minimum of 5 years. Urology 2007, 69:338-342.
7. Hashine K., Yuasa A., Shinomori K., Ninomiya I., Kataoka M., Yamashita N. Health-related quality of life after radical retropubic prostatectomy and permanent prostate brachytherapy: a 3-year follow-up study. Int J Urol - Off J Jpn Urol Assoc 2011, 18:813-819.
8. Pinkawa M., Asadpour B., Piroth M.D., Gagel B., Nussen S., Kehl M., et al. Health-related quality of life after permanent I-125 brachytherapy and conformal external beam radiotherapy for prostate cancer-a matched-pair comparison. Radiother Oncol 2009, 91:225-231.
9. Alqathami M., Blencowe A., Yeo U.J., Franich R., Doran S., Qiao G., et al. Enhancement of radiation effects by bismuth oxide nanoparticles for kilovoltage X-ray beams: a dosimetric study using a novel multi-compartment 3D radiochromic dosimeter. JPhys Conf Ser 2013, 444.
10. Preihs C., Arambula J.F., Lynch V.M., Siddik Z.H., Sessler J.L. Bismuth- and lead-texaphyrin complexes: towards potential alpha-core emitters for radiotherapy. Chem Commun 2010, 46:7900-7902.
11. 3 crystals. Phys Status Solidi B 2002, 232:220-230.
12. 3/PLGA nanocapsule for combined HIFU/radiation therapy. Biomaterials 2014, 35:8197-8205.
13. Huang H.H., Chen J., Meng Y.Z., Yang X.Q., Zhang M.Z., Yu Y., et al. Synthesis and characterization of Bi2S3 composite nanoparticles with high X-ray absorption. Mater Res Bull 2013, 48:3800-3804.
14. 3 nanodots as a contrast agent for invivo X-ray computed tomography imaging. Adv Mater 2011, 23:4886-4891.
15. Porta F., Lamers G.E.M., Morrhayim J., Chatzopoulou A., Schaaf M., den Dulk H., et al. Folic acid-modified mesoporous silica nanoparticles for cellular and nuclear targeted drug delivery. Adv Healthc Mater 2013, 2:281-286.
16. Zhang Q., Wang X.L., Li P.Z., Nguyen K.T., Wang X.J., Luo Z., et al. Biocompatible, uniform, and redispersible mesoporous silica nanoparticles for cancer- targeted drug delivery invivo. Adv Funct Mater 2014, 24:2450-2461.
17. Shen S., Tang H.Y., Zhang X.T., Ren J.F., Pang Z.Q., Wang D.G., et al. Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation. Biomaterials 2013, 34:3150-3158.
18. Teng I.T., Chang Y.J., Wang L.S., Lu H.Y., Wu L.C., Yang C.M., et al. Phospholipid-functionalized mesoporous silica nanocarriers for selective photodynamic therapy of cancer. Biomaterials 2013, 34:7462-7470.
19. Tarn D., Ashley C.E., Xue M., Carnes E.C., Zink J.I., Brinker C.J. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility. Accounts Chem Res 2013, 46:792-801.
20. Lee J.E., Lee N., Kim H., Kim J., Choi S.H., Kim J.H., et al. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. JAm Chem Soc 2010, 132:552-557.
21. Gao Y., Chen Y., Ji X.F., He X.Y., Yin Q., Zhang Z.W., et al. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. Acs Nano 2011, 5:9788-9798.
22. Hu S.H., Chen S.Y., Gao X.H. Multifunctional nanocapsules for simultaneous encapsulation of hydrophilic and hydrophobic compounds and on-demand release. Acs Nano 2012, 6:2558-2565.
23. Meng H., Mai W.X., Zhang H.Y., Xue M., Xia T., Lin S.J., et al. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer invitro and invivo. Acs Nano 2013, 7:994-1005.
24. Kim J., Kim H.S., Lee N., Kim T., Kim H., Yu T., et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed 2008, 47:8438-8441.
25. Kobayashi Y., Inose H., Nagasu R., Nakagawa T., Kubota Y., Gonda K., et al. X-ray imaging technique using colloid solution of Au/silica/poly(ethylene glycol) nanoparticles. Mater Res Innov 2013, 17:507-514.
26. Teng Z.G., Li J., Yan F., Zhao R., Yang W.S. Highly magnetizable superparamagnetic iron oxide nanoparticles embedded mesoporous silica spheres and their application for efficient recovery of DNA from agarose gel. JMater Chem 2009, 19:1811-1815.
27. Kim T., Momin E., Choi J., Yuan K., Zaidi H., Kim J., et al. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T-1 contrast agents for labeling and MRI tracking of adipose-derived mesenchyrnal stem cells. JAm Chem Soc 2011, 133:2955-2961.
28. Lee C.H., Cheng S.H., Huang I.P., Souris J.S., Yang C.S., Mou C.Y., et al. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. Angew Chem Int Ed 2010, 49:8214-8219.
29. Pan L.M., Liu J.A., He Q.J., Wang L.J., Shi J.L. Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles. Biomaterials 2013, 34:2719-2730.
30. Ma M., Chen H.R., Chen Y., Wang X., Chen F., Cui X.Z., et al. Au capped magnetic core/mesoporous silica shell nanoparticles for combined photothermo-/chemo-therapy and multimodal imaging. Biomaterials 2012, 33:989-998.
31. 2 hollow mesoporous spheres as carriers for drug delivery. Small 2010, 6:471-478.
32. Chang B.S., Guo J., Liu C.Y., Qian J., Yang W.L. Surface functionalization of magnetic mesoporous silica nanoparticles for controlled drug release. JMater Chem 2010, 20:9941-9947.
33. Liu P.D., Huang Z.H., Chen Z.W., Xu R.Z., Wu H., Zang F.C., et al. Silver nanoparticles: a novel radiation sensitizer for glioma. Nanoscale 2013, 5:11829-11836.
34. Levine B., Hoffman H., Freedlander S.O. Distribution and effect of colloidal chromic phosphate (P-32) injected into the hepatic artery and portal vein of dogs and man. Cancer 1957, 10:164-172.
35. Wang X.M., Yin Z.Y., Yu R.X., Peng Y.Y., Liu P.G., Wu G.Y. Preventive effect of regional radiotherapy with phosphorus-32 glass microspheres in hepatocellular carcinoma recurrence after hepatectomy. World J Gastroenterol - WJG 2008, 14:518-523.